Notice Number: NOT-DA-20-051
Key Dates
Release Date: April 28, 2020
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this Notice is to inform interested applicants of an additional cycle of receipt dates added to the Funding Opportunity Announcement (FOA) RFA-DA-20-028, Implementing the HIV Service Cascade for Justice-Involved Populations (U01 Clinical Trial Required). The new receipt date added to the FOA is November 13, 2020 for all applications.
As a result, the Key Dates section of the FOA has been modified as follows:
Part 1. Overview Information
Key Dates
Currently Reads:
Application Due Date(s)
Only accepting applications for the AIDS Application Due Date(s) listed below.
AIDS Application Due Date(s)
April 30, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this Funding Opportunity Announcement.
Scientific Merit Review
July 2020
Advisory Council Review
August 2020
Earliest Start Date
September 2020
Expiration Date
May 01, 2020
Modified to Read:
Application Due Date(s)
Only accepting applications for the AIDS Application Due Date(s) listed below.
AIDS Application Due Date(s)
April 30, 2020; November 13, 2020; by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
July 2020; February 2021
Advisory Council Review
August 2020; May 2021
Earliest Start Date
September 2020; July 2021
Expiration Date
November 14, 2020
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Minnjuan Flournoy Floyd, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6474
Email: Minnjuan.flournoyfloyd@nih.gov